|4Sep 29, 5:01 PM ET

Drutz David 4

4 · Altimmune, Inc. · Filed Sep 29, 2023

Insider Transaction Report

Form 4
Period: 2023-09-28
Drutz David
Director
Transactions
  • Award

    Stock Options (option to buy)

    2023-09-28+26,10026,100 total
    Exercise: $2.50Exp: 2033-09-28Common Stock, par value $0.0001 (26,100 underlying)
Footnotes (1)
  • [F1]The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 28, 2023, subject to the reporting person's continued service through the applicable vesting date.

Documents

1 file
  • 4
    tm2327241-7_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT